Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CAR-T
Biotech
Allogene’s off-the-shelf CAR-T erases lingering lymphoma cells
Cema-cel eradicated minimal residual disease in seven of 12 patients, compared to two of 12 participants in the observational control arm.
Darren Incorvaia
Apr 13, 2026 7:45am
China’s Oricell raises $110M for CAR-T plans ahead of IPO push
Apr 10, 2026 4:11am
CAR-T drives 3 autoimmune diseases into remission in one patient
Apr 9, 2026 11:00am
After 3 acquisitions, Gilead shifts focus to expanded pipeline
Apr 8, 2026 4:00am
AstraZeneca in vivo data shows potential, despite patient death
Mar 27, 2026 11:00am
Fierce Pharma
AZ to build cell therapy supply hub, R&D center in Shanghai
Mar 19, 2026 10:20am
